T cell immunity ameliorates COVID-19 disease severity and provides post-exposure prophylaxis after peptide-vaccination, in Syrian hamsters
BackgroundThe emergence of novel SARS-CoV-2 variants that resist neutralizing antibodies drew the attention to cellular immunity and calls for the development of alternative vaccination strategies to combat the pandemic. Here, we have assessed the kinetics of T cell responses and protective efficacy...
Main Authors: | Eszter Somogyi, Mariann Kremlitzka, Zsolt Csiszovszki, Levente Molnár, Orsolya Lőrincz, József Tóth, Leon de Waal, Sofie Pattijn, Wencke Reineking, Andreas Beineke, Enikő R. Tőke |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2023-01-01
|
Series: | Frontiers in Immunology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fimmu.2023.1111629/full |
Similar Items
-
In Silico Model Estimates the Clinical Trial Outcome of Cancer Vaccines
by: Orsolya Lőrincz, et al.
Published: (2021-11-01) -
A Peptide Vaccine Candidate Tailored to Individuals' Genetics Mimics the Multi-Targeted T Cell Immunity of COVID-19 Convalescent Subjects
by: Eszter Somogyi, et al.
Published: (2021-06-01) -
Single DermaVir immunization: dose-dependent expansion of precursor/memory T cells against all HIV antigens in HIV-1 infected individuals.
by: Julianna Lisziewicz, et al.
Published: (2012-01-01) -
A SZERVEZETFEJLESZTÉS SZÜKSÉGESSÉGE AZ ISKOLÁKBAN
by: Albert-Lőrincz Enikő, et al.
Published: (2016-07-01) -
Three Decades of REDOR in Protein Science: A Solid-State NMR Technique for Distance Measurement and Spectral Editing
by: Orsolya Toke
Published: (2023-09-01)